f | { | f | { |
n | | n | "author": "", |
| | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "d9dc5e79-b72e-4d3d-8ca7-50ea83e4150f", | | "id": "d9dc5e79-b72e-4d3d-8ca7-50ea83e4150f", |
| "isopen": false, | | "isopen": false, |
n | "license_title": null, | n | "license_id": "notspecified", |
| | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:11:54.805423", | | "metadata_created": "2021-09-16T08:11:54.805423", |
n | "metadata_modified": "2022-04-05T00:49:47.680913", | n | "metadata_modified": "2022-04-27T07:57:44.348566", |
| "name": "malawi-integrated-hiv-program-report-2013-q4", | | "name": "malawi-integrated-hiv-program-report-2013-q4", |
n | | n | "notes": "A summary of the key achievements between October and |
| | | December 2013 is provided below:\r\n\r\n* Scale-up of integrated HIV |
| | | services had reached the following number of sites:\r\n\r\n * |
| | | __825__ static (607 within and 218 outside of health facilities) and |
| | | 534 outreach HTC sites\r\n\r\n * __689__ (static) ART |
| | | sites\r\n\r\n * __594__ PMTCT sites (Option B+)\r\n\r\n * |
| | | __634__ Pre-ART sites\r\n\r\n * __612__ sites with HIV-exposed |
| | | child follow-up\r\n\r\n* __374,456__ persons were tested and |
| | | counselled for HIV and __32,654 (9%)__ were HIV positive;\r\n__138,000 |
| | | (37%)__ people tested for the first time.\r\n\r\n* __18,648 (97%)__ of |
| | | __19,172__ blood units collected were screened for HIV, hepatitis B |
| | | and syphilis.\r\n\r\n* __129,368 (83%)__ of __156,528__ women at ANC |
| | | had their HIV status ascertained; __10,354 (8%)__ of\r\nthese were HIV |
| | | positive. __118,217 (91%) __of __128,675__ women at maternity had |
| | | their HIV status\r\nascertained; __9,066 (8%)__ of these were HIV |
| | | positive.\r\n\r\n* _ 23,334__ patients started ART during this |
| | | quarter; this is a 10% decline from the previous\r\nquarter |
| | | (25,551).\r\n\r\n* __472,865__ patients were alive and on ART by end |
| | | of December 2013. This is equivalent to 79%\r\ncoverage of the |
| | | estimated __602,000__ population in need of ART (all ages).1 Estimated |
| | | ART\r\ncoverage among children (<15 years) and adults was 48% and 84%, |
| | | respectively.\r\n\r\n* __78%__ of adults and __81%__ of children were |
| | | retained alive on ART at 12 months after initiation.\r\n\r\n* __ |
| | | 381,477 (87%)__ of __424,961__ on first line adult ART were on regimen |
| | | 5A (TDF/3TC/EFV).\r\n\r\n* The proportion of ART patients with |
| | | documented side effects was 2%. This is a significant\r\ndecline from |
| | | 7% before transition to 5A.\r\n\r\n* A total of __11,815__ HIV |
| | | positive pregnant women were on ART: __5,271 (45%)__ of these |
| | | were\r\nalready on ART when getting pregnant and __6,544 (57%)__ |
| | | started ART during\r\npregnancy/delivery. This is equivalent to 75% |
| | | ART coverage among the estimated __15,750__\r\nHIV infected pregnant |
| | | women in Malawi this quarter.\r\n\r\n* An additional __1,721__ |
| | | breastfeeding women started ART due to Option B+ (in WHO stage |
| | | 1/2)\r\n\r\n* __5,798 (79%)__ of __7,952__ women started under Option |
| | | B+ were retained at 6 months after ART\r\ninitiation; __5,280 (73%)__ |
| | | of __8,012__ were retained at 12 months after ART initiation; __7,452 |
| | | (71%)__\r\nof __11,714__ were retained at 24 months after ART |
| | | initiation. This confirms for the first time\r\nthat a high proportion |
| | | of women started under Option B+ remain on ART beyond the\r\ncessation |
| | | of breastfeeding.\r\n\r\n* __8,663 (8%)__ of infants discharged alive |
| | | from maternity were known to be HIV exposed, __7,793\r\n(90%)__ of |
| | | these received ARV prophylaxis (nevirapine). __5,487 (63%)__ were |
| | | enrolled in exposed\r\nchild follow-up before age 2 months.\r\n\r\n* |
| | | A total of __9,207__ HIV exposed children and __7,735__ pre-ART |
| | | patients were enrolled for followup\r\nin HIV Care Clinics (HCC) |
| | | during this quarter.\r\n\r\n* __117__ medical staff were newly trained |
| | | and certified in PMTCT/ART this quarter. This brings\r\nthe total |
| | | number trained in the 2011 ART/PMTCT guidelines to __6,162__.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
n | "description": "Department of HIV & AIDS and Viral Hepatitis", | n | "description": "The Department of HIV & AIDS (DHA) was established |
| | | in 2001, initially as a unit in the Department of Clinical Services, |
| | | to coordinate the biomedical HIV Program in Malawi. The department now |
| | | carries responsibility for various HIV related programs including: |
| | | sexually transmitted infections (STIs), prevention of mother to child |
| | | transmission of HIV (PMTCT), and national voluntary male medical |
| | | circumcision program (VMMC). All these HIV program sub-sections are |
| | | linked to one robust monitoring and evaluation sub-section in the HIV |
| | | and AIDS Department which technically operates under the Central |
| | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
n | "image_url": "", | n | "image_url": |
| | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
t | "title": "Department of HIV & AIDS", | t | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:55:51.658746", | | "created": "2022-03-23T19:55:51.658746", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "523761f2-73cb-4fd5-8dd4-f9da877d7f14", | | "id": "523761f2-73cb-4fd5-8dd4-f9da877d7f14", |
| "last_modified": "2022-04-05T00:49:47.667869", | | "last_modified": "2022-04-05T00:49:47.667869", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2013-q4", | | "dha/malawi-integrated-hiv-program-report-2013-q4", |
| "metadata_modified": "2022-04-05T00:49:47.695213", | | "metadata_modified": "2022-04-05T00:49:47.695213", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2013-q4", | | "name": "malawi-integrated-hiv-program-report-2013-q4", |
| "package_id": "d9dc5e79-b72e-4d3d-8ca7-50ea83e4150f", | | "package_id": "d9dc5e79-b72e-4d3d-8ca7-50ea83e4150f", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "c430b22f108ef63922b3bdef580a7db5533779b9d151d383dd9afbd794324077", | | "c430b22f108ef63922b3bdef580a7db5533779b9d151d383dd9afbd794324077", |
| "size": 1769766, | | "size": 1769766, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| da877d7f14/download/malawi-integrated-hiv-program-report-2013-q4.pdf", | | da877d7f14/download/malawi-integrated-hiv-program-report-2013-q4.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2013 Q4", | | "title": "Malawi Integrated HIV Program Report 2013 Q4", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2013" | | "year": "2013" |
| } | | } |